Literature DB >> 27052995

microRNA profiling: increased expression of miR-147a and miR-518e in progressive supranuclear palsy (PSP).

Roman Tatura1, Malte Buchholz2, Dennis W Dickson3, John van Swieten4, Catriona McLean5, Günter Höglinger6, Ulrich Müller7.   

Abstract

Progressive supranuclear palsy is a sporadic neurodegenerative disorder. Genetic, environmental, and possibly epigenetic factors contribute to disease. In order to better understand the potential role of epigenetic changes in progressive supranuclear palsy, we investigated whether some microRNAs and their target genes are dysregulated. We analyzed expression of 372 well-characterized microRNAs in forebrains of a total of 40 patients and of 40 controls using TaqMan arrays and SYBR Green quantitative real-time PCR. The exploratory cohort included forebrains from 20 patients and 20 controls provided by the Erasmus Medical Centre in Rotterdam, Netherlands. Confirmatory samples were from Jacksonville, Florida, and from Melbourne, Australia. Both microRNA profiling and SYBR Green quantitative real-time PCR revealed significant upregulation of miR-147 (miR-147a) and miR-518e in the exploratory cohort. Highly increased expression of these two microRNAs was validated in the confirmatory samples. Target genes of miR-147a (NF1, ACLY, ALG12) and of miR-518e (CPEB1, JAZF1, RAP1B) were repressed in patients' forebrains. The results suggest that dysregulation of specific microRNAs contributes to disease by repressing target genes involved in various cellular functions.

Entities:  

Keywords:  Brain; Progressive supranuclear palsy; SYBR Green; TaqMan; miR; microRNA

Mesh:

Substances:

Year:  2016        PMID: 27052995     DOI: 10.1007/s10048-016-0480-6

Source DB:  PubMed          Journal:  Neurogenetics        ISSN: 1364-6745            Impact factor:   2.660


  20 in total

Review 1.  Cytoplasmic RNA-binding proteins and the control of complex brain function.

Authors:  Jennifer C Darnell; Joel D Richter
Journal:  Cold Spring Harb Perspect Biol       Date:  2012-08-01       Impact factor: 10.005

Review 2.  microRNA functions.

Authors:  Natascha Bushati; Stephen M Cohen
Journal:  Annu Rev Cell Dev Biol       Date:  2007       Impact factor: 13.827

3.  Cytokine expression and microglial activation in progressive supranuclear palsy.

Authors:  Rafael Fernández-Botrán; Zeshan Ahmed; Fabián A Crespo; Chandler Gatenbee; John Gonzalez; Dennis W Dickson; Irene Litvan
Journal:  Parkinsonism Relat Disord       Date:  2011-07-07       Impact factor: 4.891

4.  Evaluation of quantitative miRNA expression platforms in the microRNA quality control (miRQC) study.

Authors:  Pieter Mestdagh; Nicole Hartmann; Lukas Baeriswyl; Ditte Andreasen; Nathalie Bernard; Caifu Chen; David Cheo; Petula D'Andrade; Mike DeMayo; Lucas Dennis; Stefaan Derveaux; Yun Feng; Stephanie Fulmer-Smentek; Bernhard Gerstmayer; Julia Gouffon; Chris Grimley; Eric Lader; Kathy Y Lee; Shujun Luo; Peter Mouritzen; Aishwarya Narayanan; Sunali Patel; Sabine Peiffer; Silvia Rüberg; Gary Schroth; Dave Schuster; Jonathan M Shaffer; Elliot J Shelton; Scott Silveria; Umberto Ulmanella; Vamsi Veeramachaneni; Frank Staedtler; Thomas Peters; Toumy Guettouche; Linda Wong; Jo Vandesompele
Journal:  Nat Methods       Date:  2014-06-29       Impact factor: 28.547

5.  MicroRNA-132 loss is associated with tau exon 10 inclusion in progressive supranuclear palsy.

Authors:  Pascal Y Smith; Charlotte Delay; Johanne Girard; Marie-Amélie Papon; Emmanuel Planel; Nicolas Sergeant; Luc Buée; Sébastien S Hébert
Journal:  Hum Mol Genet       Date:  2011-08-01       Impact factor: 6.150

6.  A role of CPEB1 in the modulation of proliferation and neuronal maturation of rat primary neural progenitor cells.

Authors:  Ki Chan Kim; Ji-Woon Kim; Chang Soon Choi; Sun Young Han; Jae Hoon Cheong; Seol-Heui Han; Sung-Il Yang; Geon Ho Bahn; Chan Young Shin
Journal:  Neurochem Res       Date:  2013-07-04       Impact factor: 3.996

7.  Gene-environment interactions between JAZF1 and occupational and household lead exposure in prostate cancer among African American men.

Authors:  Christine Neslund-Dudas; Albert M Levin; Jennifer L Beebe-Dimmer; Cathryn H Bock; Nora L Nock; Andrew Rundle; Michelle Jankowski; Richard Krajenta; Q Ping Dou; Bharati Mitra; Deliang Tang; Timothy R Rebbeck; Benjamin A Rybicki
Journal:  Cancer Causes Control       Date:  2014-05-07       Impact factor: 2.506

8.  miR-147, a microRNA that is induced upon Toll-like receptor stimulation, regulates murine macrophage inflammatory responses.

Authors:  Gang Liu; Arnaud Friggeri; Yanping Yang; Young-Jun Park; Yuko Tsuruta; Edward Abraham
Journal:  Proc Natl Acad Sci U S A       Date:  2009-08-31       Impact factor: 11.205

9.  Identification of differentially expressed microRNAs across the developing human brain.

Authors:  M N Ziats; O M Rennert
Journal:  Mol Psychiatry       Date:  2013-08-06       Impact factor: 15.992

10.  Appoptosin-Mediated Caspase Cleavage of Tau Contributes to Progressive Supranuclear Palsy Pathogenesis.

Authors:  Yingjun Zhao; I-Chu Tseng; Charles J Heyser; Edward Rockenstein; Michael Mante; Anthony Adame; Qiuyang Zheng; Timothy Huang; Xin Wang; Pharhad E Arslan; Paramita Chakrabarty; Chengbiao Wu; Guojun Bu; William C Mobley; Yun-Wu Zhang; Peter St George-Hyslop; Eliezer Masliah; Paul Fraser; Huaxi Xu
Journal:  Neuron       Date:  2015-09-02       Impact factor: 17.173

View more
  10 in total

1.  Profiling of Argonaute-2-loaded microRNAs in a mouse model of frontotemporal dementia with parkinsonism-17.

Authors:  Aidan Kenny; Félix Hernández; Jesús Avila; José J Lucas; David C Henshall; Jochen Hm Prehn; Eva M Jiménez-Mateos; Tobias Engel
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2018-12-25

2.  Plasma microRNAs as a Potential Biomarker for Identification of Progressive Supranuclear Palsy.

Authors:  Palaniswamy Ramaswamy; Rita Christopher; Pramod Kumar Pal; Monojit Debnath; Ravi Yadav
Journal:  Diagnostics (Basel)       Date:  2022-05-11

Review 3.  Evolving concepts in progressive supranuclear palsy and other 4-repeat tauopathies.

Authors:  Maria Stamelou; Gesine Respondek; Nikolaos Giagkou; Jennifer L Whitwell; Gabor G Kovacs; Günter U Höglinger
Journal:  Nat Rev Neurol       Date:  2021-08-23       Impact factor: 42.937

4.  HOXD-AS1 functions as an oncogenic ceRNA to promote NSCLC cell progression by sequestering miR-147a.

Authors:  Qinghua Wang; Shujun Jiang; Anying Song; Siyuan Hou; Qinfeng Wu; Longju Qi; Xiang Gao
Journal:  Onco Targets Ther       Date:  2017-09-28       Impact factor: 4.147

5.  Epigenome-wide DNA methylation profiling in Progressive Supranuclear Palsy reveals major changes at DLX1.

Authors:  Axel Weber; Sigrid C Schwarz; Jörg Tost; Dietrich Trümbach; Pia Winter; Florence Busato; Pawel Tacik; Anita C Windhorst; Maud Fagny; Thomas Arzberger; Catriona McLean; John C van Swieten; Johannes Schwarz; Daniela Vogt Weisenhorn; Wolfgang Wurst; Till Adhikary; Dennis W Dickson; Günter U Höglinger; Ulrich Müller
Journal:  Nat Commun       Date:  2018-07-26       Impact factor: 14.919

6.  A cerebrospinal fluid microRNA analysis: Progressive supranuclear palsy.

Authors:  Wakako Nonaka; Tadayuki Takata; Hisakazu Iwama; Satoshi Komatsubara; Hideki Kobara; Masaki Kamada; Kazushi Deguchi; Tetsuo Touge; Osamu Miyamoto; Takehiro Nakamura; Toshifumi Itano; Tsutomu Masaki
Journal:  Mol Med Rep       Date:  2022-01-18       Impact factor: 2.952

Review 7.  MicroRNA as Candidate Biomarkers in Atypical Parkinsonian Syndromes: Systematic Literature Review.

Authors:  Anastasia Bougea
Journal:  Medicina (Kaunas)       Date:  2022-03-26       Impact factor: 2.948

8.  Differentially Expressed miRNAs in Age-Related Neurodegenerative Diseases: A Meta-Analysis.

Authors:  Ocana Noronha; Lucia Mesarosovo; Jasper J Anink; Anand Iyer; Eleonora Aronica; James D Mills
Journal:  Genes (Basel)       Date:  2022-06-09       Impact factor: 4.141

Review 9.  MiR-147: Functions and Implications in Inflammation and Diseases.

Authors:  Ling Lin; Kebin Hu
Journal:  Microrna       Date:  2021

Review 10.  The Functional Role of microRNAs in the Pathogenesis of Tauopathy.

Authors:  Domenico Praticò
Journal:  Cells       Date:  2020-10-09       Impact factor: 6.600

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.